| Dr David Gellman, MD | |
|
7901 Broadway, Elmhurst, NY 11373-1329 | |
| (718) 334-4000 | |
| Not Available |
| Full Name | Dr David Gellman |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 7901 Broadway, Elmhurst, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255466363 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | A101758 (California) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 312793 (New York) | Primary |
| Entity Name | New York City Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208127 PECOS PAC ID: 4183535305 Enrollment ID: O20040322001521 |
News Archive
Ligand Pharmaceuticals Incorporated announced that it has completed the acquisition of Metabasis Therapeutics, Inc. (NASDAQ:MBRX), following approval of the transaction by Metabasis stockholders yesterday. As a result, Ligand gains a fully funded partnership with Roche, additional pipeline assets and drug discovery technologies and resources. The transaction was first announced on October 27, 2009.
The Wall Street Journal reports on how such arrangments sometimes create an incentive for surgeons to do more operations, which raises quality issues and health care costs.
Researchers at Johns Hopkins have found a better way to create induced pluripotent stem cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.
One of the most interesting and fastest developing areas in healthcare is the use of light to diagnose and treat medical conditions and illnesses, collectively known as Healthcare Photonics. It includes a range of new phototherapies as well as bio-medical imaging and in vitro diagnostics. The area offers huge potential for the UK and the global healthcare sector. Applications are wide ranging from wound, skin and cancer care to niche applications in neurology and ophthalmology.
Arrowhead Research Corporation today announced that its Unidym, Inc. subsidiary has been acquired by Wisepower Co., Ltd., a publicly-traded, Seoul, Korea-based electronics company. Upfront consideration to Unidym shareholders consists of Wisepower stock and convertible bonds valued at US $5,000,000 with certain restrictions as to timing of stock sales.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Gellman, MD Po Box 790, Beacon, NY 12508-0790 Ph: (718) 334-4000 | Dr David Gellman, MD 7901 Broadway, Elmhurst, NY 11373-1329 Ph: (718) 334-4000 |
News Archive
Ligand Pharmaceuticals Incorporated announced that it has completed the acquisition of Metabasis Therapeutics, Inc. (NASDAQ:MBRX), following approval of the transaction by Metabasis stockholders yesterday. As a result, Ligand gains a fully funded partnership with Roche, additional pipeline assets and drug discovery technologies and resources. The transaction was first announced on October 27, 2009.
The Wall Street Journal reports on how such arrangments sometimes create an incentive for surgeons to do more operations, which raises quality issues and health care costs.
Researchers at Johns Hopkins have found a better way to create induced pluripotent stem cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.
One of the most interesting and fastest developing areas in healthcare is the use of light to diagnose and treat medical conditions and illnesses, collectively known as Healthcare Photonics. It includes a range of new phototherapies as well as bio-medical imaging and in vitro diagnostics. The area offers huge potential for the UK and the global healthcare sector. Applications are wide ranging from wound, skin and cancer care to niche applications in neurology and ophthalmology.
Arrowhead Research Corporation today announced that its Unidym, Inc. subsidiary has been acquired by Wisepower Co., Ltd., a publicly-traded, Seoul, Korea-based electronics company. Upfront consideration to Unidym shareholders consists of Wisepower stock and convertible bonds valued at US $5,000,000 with certain restrictions as to timing of stock sales.
› Verified 8 days ago
Dr. Martin Holiday Maurer, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7901 Broadway, Elmhurst, NY 11373 Phone: 718-334-3900 Fax: 718-334-5958 | |
Dr. Douglas Alan Landy, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7901 Broadway # D10-38, Elmhurst, NY 11373 Phone: 718-334-3512 Fax: 718-344-5006 | |
Dipak Nandi, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4142 Elbertson St, 102, Elmhurst, NY 11373 Phone: 718-505-1300 Fax: 718-505-1883 | |
David Yohai, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7901 Broadway, Room A1 9, Elmhurst, NY 11373 Phone: 718-334-4952 Fax: 718-334-4815 | |
Dr. Charles Thomas Barron, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 80th St & 41st Ave, Elmhurst, NY 11373 Phone: 718-334-3900 Fax: 718-334-5958 | |
Emmanuelle J Duterte, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7901 Broadway # D10-38, Elmhurst, NY 11373 Phone: 718-334-3501 Fax: 718-334-5006 | |
Dr. Anna J Holmgren, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 80th St & 41st Ave, Elmhurst, NY 11373 Phone: 718-334-3900 Fax: 718-334-5958 |